ADS Clinical Symposium & Orals: Clinical Trials Update
Tracks
Breakout 1: Riverside Theatre
Friday, August 23, 2024 |
11:00 AM - 1:00 PM |
Riverside Theatre (Plenary) |
Speaker
Prof Vlado Perkovic
Provost UNSW, Sydney
University of New South Wales, Sydney, Australia
An overview of the FLOW trial
11:00 AM - 12:00 PMBiography
Professor Perkovic is the Provost and Scientia Professor at the University of New South Wales. He is a leading trialist in Nephrology, having led several landmark studies that have defined clinical practice.
Prof Richard MacIsaac
Director, Department of Endocrinology & Diabetes
St Vincent's Hospital Melbourne
An overview of the FLOW trial
11:00 AM - 12:00 PMBiography
Richard MacIsaac is a clinician-researcher who is currently Professor and Director of Endocrinology and Diabetes at St Vincent’s Hospital Melbourne and the University of Melbourne, Victoria, Australia. He is also the diabetes kidney disease co-stream leader for the Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne. He has been a principal investigator for numerous diabetes clinical trials related to cardiovascular and kidney outcomes, including the landmark LEADER, SUSTAIN 6, CANVAS R, SCORED, FIGARO, FIDELIO and FLOW studies. His main research interest is diabetes and its acute and chronic complications, especially those related to cardiovascular and kidney disease. He has published over 300 research articles. His current specific research interests include inpatient glycaemic control, defining the albuminuria and glomerular filtration rate relationship in diabetes, investigating new biomarkers for kidney and vascular disease in diabetes and studying kidney function in Australian Aboriginal and Torres Strait Islander people.
Prof Sarah Glastras
Senior Staff Specialist In Endocrinology
Royal North Shore Hospital
Impact of once-weekly Subcutaneous Semaglutide 2.4 mg on Metabolic Syndrome in the 2-year, randomised controlled STEP 5 trial
12:00 PM - 12:15 PMBiography
A/Prof Glastras is Staff Specialist in Endocrinology at Royal North Shore Hospital, and conjoint Associate Professor at the University of Sydney. Her research focuses on diabetes, obesity and pregnancy. She currently chairs her local district Diabetes Clinical Advisory Group and is the Australian Centre for Accelerating Diabetes Innovations Training Lead.
Prof John Dixon
Adjunct Swinburne Professor
Iverson Health Innovation Research Institute / Swinburne University of Technology
Once-weekly Subcutaneous Semaglutide 2.4 mg in Adolescents with Overweight or Obesity
12:15 PM - 12:30 PMBiography
An experienced research clinician, John is known globally for his breadth of research into obesity and its risks and complications as well as weight loss treatments and their effects on health. He has over 350 original research and review publications. John is focused on reducing weight stigma, improving access care.
Prof Sarah Glastras
Senior Staff Specialist In Endocrinology
Royal North Shore Hospital
Effect of Tirzepatide on Kidney Parameters in People with Excess Body Weight and Type 2 Diabetes: A Post-Hoc Analysis of the SURMOUNT-2 Trial
12:30 PM - 12:45 PMBiography
A/Prof Sarah Glastras is a clinician researcher who works as a Staff Specialist in Endocrinology at the Royal North Shore Hospital, Sydney and holds a conjoint appointment as an academic Associate Professor at the University of Sydney.
A/Prof Samantha Hocking
A/Prof Diabetes NSW & ACT
Royal Prince Alfred Hospital / Central Clinical School / The University of Sydney
Tirzepatide reduced Sleep Apnea severity in Adults with Obstructive Sleep Apnea and Obesity: Results from the SURMOUNT-OSA trial.
12:45 PM - 1:00 PMBiography
A/Prof Hocking's expertise extends across a broad range of endocrine disorders, including diabetes, thyroid disorders, pituitary diseases, and adrenal disorders. She stays updated with the latest advancements and research in the field, incorporating evidence-based medicine into her practice.
Prof Roger Chen
Professor
The University of Sydney / University of NSW / St Vincent's Hospital
Chairperson
11:00 AM - 1:00 PMBiography
Roger Chen is an endocrinologist at St Vincent’s Hospital, Sydney with interests in diabetes, diabetes and mental illness and transplant-related endocrine disorders.
Prof Sophia Zoungas
Head, School of Public Health and Preventive Medicine
Monash University
Chairperson
11:00 AM - 1:00 PMBiography
Prof. Sophia Zoungas, MBBS, FRACP, PhD, is the head of Monash University's School of Public Health and Preventive Medicine, and leads the School's Diabetes Research Program. She is an endocrinologist with clinical appointments at both Alfred Health and Monash Health, Melbourne, Victoria, Australia. She leads clinical and health services research groups and collaborates extensively both locally and internationally in the specialty area of diabetes, cardiovascular disease, kidney disease, and health aging. Sophia has over 250 publications in peer-reviewed journals.